Dermatomyositis: all 175 studies
Page 2 of 2. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune DiseasesActive, not recruitingNCT06255028Phase 1
- Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With InflammationCompletedNCT06002750
- Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic DiseasesActive, not recruitingNCT05879419Phase 4
- Add-on Intravenous Immunoglobulins in Early MyositisActive, not recruitingNCT05832034Phase 2/3
- A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With DermatomyositisCompletedNCT05695950Phase 2
- Plexin D1 as a Potential Biomarker inPM/DMStatus unknownNCT05637931
- Transition to Adulthood Through Coaching and Empowerment in RheumatologyCompletedNCT05545839Not applicable
- Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)CompletedNCT05524311Phase 2
- A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.CompletedNCT05523167Phase 2/3
- Clinical Analysis of Juvenile Dermatomyositis PatientsCompletedNCT05509140
- Interleukin-2 on Active DermatomyositisStatus unknownNCT05495321Phase 3
- Lenalidomide in the Treatment of Refractory Cutaneous DermatomyositisStatus unknownNCT05488327Not applicable
- A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With DermatomyositisCompletedNCT05437263Phase 3
- Gastric Mucosal Changes in Patients With DermatomyositisStatus unknownNCT05402670
- Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive DermatomyositisStatus unknownNCT05375435Phase 4
- Baricitinib for Cutaneous DermatomyositisWithdrawnNCT05361109Phase 2
- Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune DiseasesStatus unknownNCT05239702Early Phase 1
- Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory MyopatiesCompletedNCT05027152Not applicable
- Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or DermatomyositisCompletedNCT04976140Phase 1/2
- The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis PatientsStatus unknownNCT04966884Phase 4
- An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory DermatomyositisStatus unknownNCT04946669Early Phase 1
- Clinical Research on Advanced Warning Factors Of Respiratory Injury in DermatomyositisStatus unknownNCT04747652
- Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)CompletedNCT04723303Early Phase 1
- Correlation Between the Change of Peripheral Lymphocyte Subsets and Clinically Amyopathic Dermatomyositis Combined With Rapidly Progressive Interstitial Lung DiseaseStatus unknownNCT04613219
- High-intensity Strength Training in MyositisCompletedNCT04486261Not applicable
- Exercise, Creatine and Coenzyme Q10 for Childhood MyositisCompletedNCT04286178Not applicable
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisCompletedNCT03817424Phase 1
- Trial to Evaluate Efficacy and Safety of Lenabasum in DermatomyositisCompletedNCT03813160Phase 3
- Juvenile DermatomyositisStatus unknownNCT03433638
- Incidence and Prevalence of Juvenile DermatomyositisStatus unknownNCT03432455
- Yellow Fever Vaccine in Patients With Rheumatic DiseasesCompletedNCT03430388Not applicable
- Predictor of Clinical Response to Acthar in MyositisCompletedNCT03414086
- Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and DermatomyositisStatus unknownNCT03324152Not applicable
- Exercise Capacity of Patients with DermatomyosisTerminatedNCT03293615Not applicable
- Basiliximab Treating Interstitial Pneumonia of CADMStatus unknownNCT03192657Phase 2
- Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary RaynaudCompletedNCT03027674Early Phase 1
- Study of Tofacitinib in Refractory DermatomyositisCompletedNCT03002649Phase 1
- Study of IFN-K in DermatomyositisWithdrawnNCT02980198Phase 2
- Study of the Prevalence of Polymyositis and Dermatomyositis in NormandyCompletedNCT02880527
- Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic DermatomyositisStatus unknownNCT02821689Phase 4
- A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune DiseasesCompletedNCT02780674Phase 1
- Denosumab for Glucocorticoid-treated Children With Rheumatic DisordersWithdrawnNCT02418273Phase 1/2
- Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept StudyTerminatedNCT02271165Early Phase 1
- The Effect of Creatine Supplementation on Muscle Function in Childhood MyositisCompletedNCT02267005Not applicable
- A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial PneumoniaCompletedNCT02159651
- Outcome in Patients With Recent Onset Polymyositis and DermatomyositisCompletedNCT01813617
- Environmental Risk Factors for Myositis in Military PersonnelCompletedNCT01734369
- Compassionate Use Protocol for the Treatment of Autoinflammatory SyndromesApproved for marketingNCT01724580
- The CARRA RegistryCompletedNCT01697254
- Dermatomyositis and Polymyositis RegistryStatus unknownNCT01637064
- Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory MyopathiesCompletedNCT01432613Not applicable
- Efficacy of an Individual Rehabilitation Program in Polymyositis and DermatomyositisCompletedNCT01415219Phase 2
- Abatacept Treatment in Polymyositis and DermatomyositisCompletedNCT01315938Phase 2
- Creatine Supplementation in Pediatric RheumatologyStatus unknownNCT01217320Not applicable
- Investigating Genes in Patients With Polymyositis and DermatomyositisActive, not recruitingNCT01171573
- Anakinra in MyositisCompletedNCT01165008Phase 2/3
- Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesStatus unknownNCT01151644Phase 4
- Hand Function in Patients With Poly- or DermatomyositisCompletedNCT00866125
- Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune DiseaseCompletedNCT00815282Phase 4
- A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or PolymyositisCompletedNCT00533091Phase 1
- Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue DiseasesCompletedNCT00341679
- Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)CompletedNCT00335985Phase 3
- myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory MyopathiesCompletedNCT00213629Not applicable
- Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile DermatomyositisCompletedNCT00059748
- Understanding the Pathogenesis and Treatment of Childhood Onset DermatomyositisTerminatedNCT00035958Phase 2/3
- Infliximab (Remicade ) to Treat Dermatomyositis and PolymyositisCompletedNCT00033891Phase 2
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune DisordersCompletedNCT00010335Phase 1
- Safety and Effectiveness of h5G1.1-mAb for DermatomyositisCompletedNCT00005571Phase 2
- Absorption of Corticosteroids in Children With Juvenile DermatomyositisCompletedNCT00004357Phase 2
- Methimazole to Treat Polymyositis and DermatomyositisCompletedNCT00001421Phase 2
- Genetic and Family Studies of Inherited Muscle DiseasesCompletedNCT00001331
- Study and Treatment of Inflammatory Muscle DiseasesCompletedNCT00001265
- Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory MyopathiesCompletedNCT00001261Phase 2